Vice President, Product and Portfolio Strategy, Genetic Diseases
Company: Beam Therapeutics
Location: Cambridge
Posted on: November 13, 2024
|
|
Job Description:
Company Overview:
Beam Therapeutics is committed to establishing the leading, fully
integrated platform for precision genetic medicines. To achieve
this vision, Beam has assembled a platform that includes a suite of
gene editing and delivery technologies and is in the process of
building internal manufacturing capabilities. Beam's suite of gene
editing technologies is anchored by base editing, a proprietary
technology that is designed to enable precise, predictable and
efficient single base changes, at targeted genomic sequences,
without making double-stranded breaks in the DNA. This has the
potential to enable a wide range of potential therapeutic editing
strategies that Beam is using to advance a diversified portfolio of
base editing programs. Beam is a values-driven organization
committed to its people, cutting-edge science, and a vision of
providing life-long cures to patients suffering from serious
diseases.
Position Overview:
Beam is looking for a highly energetic and dynamic leader as the VP
of Product and Portfolio Strategy for Genetic Disease. The VP will
be responsible for shaping the life-cycle management and the path
to commercialization for Beam's liver in vivo portfolio (e.g., BEAM
302). These therapies have the potential to be the first in vivo
base editors designed to treat serious genetic disorders with a
single infusion. The VP will be responsible for shaping the product
strategy for these medicines as well as build a global
commercialization approach.
Responsibilities:
Qualifications:
#J-18808-Ljbffr
Keywords: Beam Therapeutics, Middletown , Vice President, Product and Portfolio Strategy, Genetic Diseases, Executive , Cambridge, Connecticut
Click
here to apply!
|